Business Description
CHC Healthcare Group
NAICS : 423450
SIC : 5047
ISIN : TW0004164009
Compare
Compare
Traded in other countries / regions
4164.Taiwan IPO Date
2012-10-24Description
CHC Healthcare Group is a Taiwan based company engaged in the trading of pharmaceutical products and the sale, leasing, installation, and repair of medical instruments. It is engaged in the distribution of radiotherapy equipment, including equipment that is used in the treatment of radiation oncology, ophthalmology, dentistry, and neuroscience. It also provides medical equipment consulting for hospitals and clinics. It earns revenues from the sale of drugs, sale of medical instruments, and repairs maintenance and other services.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.39 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.81 | |||||
| Debt-to-EBITDA | 4.19 | |||||
| Interest Coverage | 6.9 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.58 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.4 | |||||
| 3-Year EBITDA Growth Rate | 9.6 | |||||
| 3-Year EPS without NRI Growth Rate | 5 | |||||
| 3-Year FCF Growth Rate | 27.4 | |||||
| 3-Year Book Growth Rate | 1.2 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.8 | |||||
| 9-Day RSI | 34.52 | |||||
| 14-Day RSI | 37.88 | |||||
| 6-1 Month Momentum % | 7.13 | |||||
| 12-1 Month Momentum % | -8.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.04 | |||||
| Quick Ratio | 2.61 | |||||
| Cash Ratio | 1.42 | |||||
| Days Inventory | 91.46 | |||||
| Days Sales Outstanding | 85.93 | |||||
| Days Payable | 44.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.49 | |||||
| Dividend Payout Ratio | 0.87 | |||||
| 3-Year Dividend Growth Rate | -0.5 | |||||
| Forward Dividend Yield % | 3.49 | |||||
| 5-Year Yield-on-Cost % | 5.62 | |||||
| 3-Year Average Share Buyback Ratio | -2.2 | |||||
| Shareholder Yield % | 0.59 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.55 | |||||
| Operating Margin % | 15.83 | |||||
| Net Margin % | 10.8 | |||||
| FCF Margin % | 9.98 | |||||
| ROE % | 6.76 | |||||
| ROA % | 3.15 | |||||
| ROIC % | 4.28 | |||||
| ROC (Joel Greenblatt) % | 8.66 | |||||
| ROCE % | 5.51 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 24.95 | |||||
| PE Ratio without NRI | 24.94 | |||||
| Shiller PE Ratio | 28.03 | |||||
| Price-to-Owner-Earnings | 23.94 | |||||
| PEG Ratio | 7.13 | |||||
| PS Ratio | 2.7 | |||||
| PB Ratio | 1.45 | |||||
| Price-to-Tangible-Book | 1.61 | |||||
| Price-to-Free-Cash-Flow | 27.5 | |||||
| Price-to-Operating-Cash-Flow | 10.82 | |||||
| EV-to-EBIT | 19.39 | |||||
| EV-to-EBITDA | 10.11 | |||||
| EV-to-Revenue | 3.24 | |||||
| EV-to-FCF | 32.14 | |||||
| Price-to-Projected-FCF | 1.43 | |||||
| Price-to-Median-PS-Value | 0.97 | |||||
| Price-to-Graham-Number | 1.34 | |||||
| Earnings Yield (Greenblatt) % | 5.15 | |||||
| FCF Yield % | 4.12 | |||||
| Forward Rate of Return (Yacktman) % | 4.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CHC Healthcare Group Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 3,877.137 | ||
| EPS (TTM) (NT$) | 2.26 | ||
| Beta | 0.58 | ||
| Volatility % | 27.45 | ||
| 14-Day RSI | 37.88 | ||
| 14-Day ATR (NT$) | 1.490013 | ||
| 20-Day SMA (NT$) | 59.42 | ||
| 12-1 Month Momentum % | -8.2 | ||
| 52-Week Range (NT$) | 52 - 75.6 | ||
| Shares Outstanding (Mil) | 166.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CHC Healthcare Group Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CHC Healthcare Group Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
CHC Healthcare Group Frequently Asked Questions
What is CHC Healthcare Group(TPE:4164)'s stock price today?
The current price of TPE:4164 is NT$56.40. The 52 week high of TPE:4164 is NT$75.60 and 52 week low is NT$52.00.
When is next earnings date of CHC Healthcare Group(TPE:4164)?
The next earnings date of CHC Healthcare Group(TPE:4164) is .
Does CHC Healthcare Group(TPE:4164) pay dividends? If so, how much?
The Dividend Yield %  of CHC Healthcare Group(TPE:4164) is 3.49% (As of Today), Highest Dividend Payout Ratio of CHC Healthcare Group(TPE:4164) was 1.77. The lowest was 0.62. And the median was 0.98. The  Forward Dividend Yield % of CHC Healthcare Group(TPE:4164) is 3.49%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers